Canada markets closed

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
13.72-0.04 (-0.29%)
At close: 03:00PM CST
Currency in CNY

Valuation Measures4

Market Cap (intraday) 12.34B
Enterprise Value 10.00B
Trailing P/E 12.47
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.35
Price/Book (mrq)1.42
Enterprise Value/Revenue 1.90
Enterprise Value/EBITDA 8.80

Trading Information

Stock Price History

Beta (5Y Monthly) 0.13
52-Week Change 3-50.52%
S&P500 52-Week Change 322.55%
52 Week High 330.79
52 Week Low 313.65
50-Day Moving Average 315.20
200-Day Moving Average 321.48

Share Statistics

Avg Vol (3 month) 314.95M
Avg Vol (10 day) 38.55M
Shares Outstanding 5899.44M
Implied Shares Outstanding 6902.06M
Float 8512.19M
% Held by Insiders 142.98%
% Held by Institutions 121.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.5
Forward Annual Dividend Yield 43.64%
Trailing Annual Dividend Rate 30.50
Trailing Annual Dividend Yield 33.63%
5 Year Average Dividend Yield 41.23
Payout Ratio 436.36%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 04, 2024
Last Split Factor 21.8:1
Last Split Date 3Apr 12, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 18.85%
Operating Margin (ttm)18.01%

Management Effectiveness

Return on Assets (ttm)5.25%
Return on Equity (ttm)11.71%

Income Statement

Revenue (ttm)5.25B
Revenue Per Share (ttm)5.84
Quarterly Revenue Growth (yoy)-15.70%
Gross Profit (ttm)N/A
EBITDA 1.35B
Net Income Avi to Common (ttm)989.32M
Diluted EPS (ttm)1.10
Quarterly Earnings Growth (yoy)-15.70%

Balance Sheet

Total Cash (mrq)4.06B
Total Cash Per Share (mrq)4.51
Total Debt (mrq)1.72B
Total Debt/Equity (mrq)19.64%
Current Ratio (mrq)2.71
Book Value Per Share (mrq)9.63

Cash Flow Statement

Operating Cash Flow (ttm)766.98M
Levered Free Cash Flow (ttm)-988.73M